Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Acute Med Surg ; 7(1): e540, 2020.
Article in English | MEDLINE | ID: mdl-33364033

ABSTRACT

The risk of encountering human-to-human infections, including emerging infectious diseases, should be adequately and appropriately addressed in the emergency department. However, guidelines based on sufficient evidence on infection control in the emergency department have not been developed anywhere in the world. Each facility examines and implements its own countermeasures. The Japanese Association for Acute Medicine has established the "Committee for Infection Control in the Emergency Department" in cooperation with the Japanese Association for Infectious Diseases, Japanese Society for Infection Prevention and Control, Japanese Society for Emergency Medicine, and Japanese Society for Clinical Microbiology. A joint working group has been established to consider appropriate measures. This group undertook a comprehensive and multifaceted review of infection control measures for emergency outpatients and related matters, and released a checklist for infection control in emergency departments. This checklist has been prepared such that even small emergency departments with few or no emergency physicians can control infection by following the checklist, without committing any major errors. The checklist includes a control system for infection control, education, screening, and vaccination, prompt response to suspected infections, and management of the risk of infection in facilities. In addition, the timing of the check and interval at which the check is carried out are specified as categories. We hope that this checklist will contribute to improving infection control in the emergency department.

2.
Acute Med Surg ; 5(4): 374-379, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30338085

ABSTRACT

AIM: Infection control in the emergency department is important for hospital risk management; however, few clinical guidelines have been established. This study aimed to determine whether hospitals in Japan have infection control manuals, and investigate the contents of manuals, consulting systems, and isolation facilities for emergency departments. METHODS: A total of 517 hospitals certified as educational institutions for board-certified acute care physicians in Japan were requested between March and May 2015 to provide a written evaluation of the infection control in the emergency department. RESULTS: A total of 51 of 303 (16.8%) hospitals had no manuals regarding infection control in the emergency department. Among 250 hospitals having emergency department manuals, 115 (46.0%) did not include contents regarding disinfection and sterilization for imaging examination rooms, and only 44 (17.6%) had criteria for contacting the emergency medical service when patients are suspected of, or diagnosed with, communicable diseases. Of the 303 hospitals, 277 (91.4%) prepared specific manuals for the 2009 pandemic influenza. Of the 303 hospitals, 80 (26.4%) did not prepare manuals for the Ebola virus disease outbreak in West Africa in 2014. Furthermore, 92 (30.4%) of the 303 hospitals did not have any negative-pressure isolation rooms. CONCLUSIONS: Practices and guidelines necessary for infection control in the emergency department were not sufficiently covered in the hospitals studied. Education, information sharing, and a checklist for preparing manuals are needed to establish better infection control systems in emergency departments.

3.
Gan To Kagaku Ryoho ; 41(12): 2524-6, 2014 Nov.
Article in Japanese | MEDLINE | ID: mdl-25731578

ABSTRACT

The management of elderly patients with malignant disease is determined by their condition, complications, and living environment. Sometimes it is difficult to judge surgical indications for elderly patients. We report 4 cases of patients, 80 years or older, who underwent an operation for malignancy. In the first case we performed a bile duct excision for bile duct cancer, and in the second case we performed distal pancreatectomy for pancreatic cancer. Both operations were non-curative, and the patients were alive and maintained quality of life for 12 months after the operation. In the third non-curative operation, we performed total gastrectomy for remnant gastric cancer. The patient died of cancer 4 months after the surgery. In the fourth case we performed pancreaticoduodenectomy for bile duct cancer; it was a curative operation. The patient was in very good condition 4 months post-operation, but died suddenly due to acute myocardial infarction. In operations treating malignancy in elderly patients, it is important for the patients and their families to fully understand the significance of the operations.


Subject(s)
Bile Duct Neoplasms/surgery , Pancreatic Neoplasms/surgery , Stomach Neoplasms/surgery , Aged, 80 and over , Fatal Outcome , Female , Humans , Male , Pancreatectomy , Quality of Life
4.
Gan To Kagaku Ryoho ; 36(8): 1287-91, 2009 Aug.
Article in Japanese | MEDLINE | ID: mdl-19692767

ABSTRACT

We evaluated the efficacy and safety of combination neoadjuvant chemotherapy consisting of S-1 and CDDP in patients with resectable advanced gastric cancer at Saitama Red Cross Hospital. Twelve patients who had lymph node metastasis preoperatively were enrolled. S-1 was given orally at 80 mg/m(2) for day 1-21 and 60 mg/m(2) of CDDP was administered on day 8. All patients were treated with a two-cycle protocol. The second cycle of the two-cycle protocol was started 14 days after the final oral administration of S-1 in the first cycle. There were no severe or unexpected adverse reactions. Preoperative response rate was 75.0%. Histological effect was judged to be grade 3 in 1 case and grade 2 in 2 cases. In the postoperative period, all patients received S-1-based adjuvant chemotherapy, but a relapse was determined in 4 patients. S-1/CDDP combination neoadjuvant chemotherapy in our hospital demonstrated high response and good compliance. However, we consider that the survival benefit of neoadjuvant chemotherapy for resectable advanced gastric cancer should be evaluated within the framework of clinical trials.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/therapy , Aged , Antimetabolites, Antineoplastic/administration & dosage , Antineoplastic Agents/administration & dosage , Cisplatin/administration & dosage , Drug Administration Schedule , Drug Combinations , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoadjuvant Therapy , Oxonic Acid/administration & dosage , Tegafur/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...